Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.
Air Products Membrane Solutions Announces $10M Investment To Significantly Increase Membrane Production Capacity At Its St. Louis Facility
Air Products (NYSE: APD), the global leader in the production of gas separation and purification membranes, today announced a project to significantly increase hollow fiber membrane production at
